Journal
JOURNAL OF PROTEOME RESEARCH
Volume 10, Issue 11, Pages 4983-4992Publisher
AMER CHEMICAL SOC
DOI: 10.1021/pr200452j
Keywords
metabonomics; metabolomics; metabolites; cardiovascular diseases; atherosclerosis; NMR spectroscopy; oxidative stress
Categories
Funding
- Transfusion Service of the Pistoia Hospital
- Boehringer Ingelheim Italia
Ask authors/readers for more resources
The identification and the present wide acceptance of cardiovascular risk factors such as age, sex, hypertension, hyperlipidemia, smoking, obesity, diabetes, and physical inactivity have led to dramatic reductions in cardiovascular morbidity and mortality. However, novel risk predictors present opportunities to identify more patients at risk and to more accurately define the biochemical signature of that risk. In this paper, we present a comprehensive metabonomic analysis of 864 plasma samples from healthy volunteers, through Nuclear Magnetic Resonance (NMR) and multivariate statistical analysis (regression and classification). We have found that subjects that are classified as at high or at low risk using the common clinical markers can also be discriminated using NMR metabonomics. This discrimination is not only due to common markers (such as total cholesterol, triglycerides, LDL, HDL), but also to (p < 0.05 after Bonferroni correction) other metabolites (e.g., 3-hydroxybutyrate, alpha-ketoglutarate, threonine, dimethylglycine) previously not associated with cardiovascular diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available